F
Francisco Torres
Researcher at University of Atacama
Publications - 7
Citations - 154
Francisco Torres is an academic researcher from University of Atacama. The author has contributed to research in topics: Polyethylene glycol & Drug delivery. The author has an hindex of 3, co-authored 7 publications receiving 122 citations.
Papers
More filters
Journal ArticleDOI
A new family of slash-distributions with elliptical contours
TL;DR: In this paper, the scale mixture of an elliptically distributed random variable with respect to the power of a U(0, 1) random variable is defined by means of a stochastic representation.
Journal ArticleDOI
Large-Sample Inference for the Epsilon-Skew-t Distribution
TL;DR: This article considers the epsilon-skew-t distribution with known and unknown degrees of freedom parameter, showing great flexibility in adjusting to skew data with heavy tails, and derives the information matrix for the maximum likelihood estimators.
Journal ArticleDOI
MgO nanoparticles coated with polyethylene glycol as carrier for 2-Methoxyestradiol anticancer drug.
Aline Alfaro,Andrea León,Emanuel Guajardo-Correa,Patricia Reuquen,Francisco Torres,Mario Mery,Rodrigo Segura,Paula A. Zapata,Pedro A. Orihuela +8 more
TL;DR: The MgO-PEG-2ME NPs decreased the viability of the prostate cancer cell line LNCap suggesting that this nanocomposite is suitable as a drug delivery system for anticancer prostate therapy.
Posted ContentDOI
MgO nanoparticles coated with Polyethylene Glycol as carrier for 2-Methoxyestradiol anticancer drug.
Aline Alfaro,Andrea León,Eduardo Guajardo,Patricia Reuquen,Francisco Torres,Mario Mery,Rodrigo Segura,Paula A. Zapata,Pedro A. Orihuela +8 more
TL;DR: The MgO-PEG-2ME NPs decreased the viability of the prostate cancer cell line LNCap suggesting that this nanocomposite is suitable as a drug delivery system for anticancer prostate therapy.
Journal ArticleDOI
High hepatitis C virus seropositivity, viremia, and associated risk factors among trans women living in San Francisco, California.
Christopher J. Hernandez,Dillon Trujillo,Sofia Sicro,Joaquin Meza,Mackie Bella,Emperatriz Daza,Francisco Torres,Willi McFarland,Caitlin Turner,Erin C. Wilson +9 more
TL;DR: In this article, the authors measured HCV seropositivity, viremia, and associated risk factors for HCV infection among trans women in San Francisco from June 2019 to February 2020.